|
| 37358378 | Exploring Interactions Between Traumatic Brain Injury History and Gender on Medical Comorbidities in Military Veterans: An Epidemiological Analysis in the VA Million Veteran Program. | J Neurotrauma | 2024 |
| 37856045 | Evaluation of clinical outcomes and employment status in veterans with dual diagnosis of traumatic brain injury and spinal cord injury. | Qual Life Res | 2024 |
| 37710416 | Measurement Invariance of the Neurobehavioral Symptom Inventory in Male and Female Million Veteran Program Enrollees Completing the Comprehensive Traumatic Brain Injury Evaluation. | Assessment | 2024 |
| 37875548 | Genome-wide association study of traumatic brain injury in U.S. military veterans enrolled in the VA million veteran program. | Mol Psychiatry | 2024 |
| 36597157 | Self-reported physical functioning, cardiometabolic health conditions, and health care utilization patterns in Million Veteran Program enrollees with Traumatic Brain Injury Screening and Evaluation Program data. | Mil Med Res | 2023 |
| 38082299 | Pharmacogenetic testing and monitoring of complete blood counts among Veterans newly prescribed thiopurine treatments: a retrospective cohort study. | J Pharm Policy Pract | 2023 |
| 37961335 | <i>CYP2C19</i> Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention (PCI) in the Million Veterans Program. | medRxiv | 2023 |
| 35652783 | Cost-effectiveness of CYP2C19-guided P2Y12 inhibitors in Veterans undergoing percutaneous coronary intervention for acute coronary syndromes. | Eur Heart J Qual Care Clin Outcomes | 2023 |
| 36702773 | An Examination of Racial/Ethnic Differences on the Neurobehavioral Symptom Inventory Among Veterans Completing the Comprehensive Traumatic Brain Injury Evaluation: A Veterans Affairs Million Veteran Program Study. | Arch Clin Neuropsychol | 2023 |
| 35319502 | Drug-drug-gene interaction risk among opioid users in the U.S. Department of Veterans Affairs. | Pain | 2022 |
| 35404460 | Demographic Differences Among US Department of Veterans Affairs Patients Referred for Genetic Consultation to a Centralized VA Telehealth Program, VA Medical Centers, or the Community. | JAMA Netw Open | 2022 |
| 35367107 | What Drives Women Veterans' Trust in VA Healthcare Providers? | Womens Health Issues | 2022 |
| 35483132 | Subjective cognitive and psychiatric well-being in U.S. Military Veterans screened for deployment-related traumatic brain injury: A Million Veteran Program Study. | J Psychiatr Res | 2022 |
| 36925876 | Implementing clinical decision support for reducing women Veterans' cardiovascular risk in VA: A mixed-method, longitudinal study of context, adaptation, and uptake. | Front Health Serv | 2022 |
| 36714216 | Characterizing Sex Differences in Clinical and Functional Outcomes Among Military Veterans with a Comprehensive Traumatic Brain Injury Evaluation (CTBIE): A Million Veteran Program (MVP) Study. | Clin Psychol Sci | 2022 |
| 36162363 | Psychiatric symptoms influence social support in VA Million Veteran Program enrollees screening positive for traumatic brain injury. | Soc Sci Med | 2022 |
| 33403869 | Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program. | Pharmacogenomics | 2021 |
| 34942434 | Characterization of Million Veteran Program (MVP) enrollees with Comprehensive Traumatic Brain Injury Evaluation (CTBIE) data: An analysis of neurobehavioral symptoms. | J Psychiatr Res | 2021 |
| 34704830 | Evaluation of the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program at initial test sites. | Pharmacogenomics | 2021 |
| 34037737 | Clinical Implications of Pharmacogenomic Testing in the Real World-Insights From a Pediatric Program. | JAMA Netw Open | 2021 |
| 32980074 | Identifying End Users' Preferences about Structuring Pharmacogenetic Test Orders in an Electronic Health Record System. | J Mol Diagn | 2020 |
| 30353149 | A logic model for precision medicine implementation informed by stakeholder views and implementation science. | Genet Med | 2019 |
| 31393222 | Early adoption of pharmacogenetic testing for veterans prescribed psychotropic medications. | Pharmacogenomics | 2019 |
| 30989651 | Exploring the association of care fragmentation and patient ratings of care quality: A mediation analysis of women Veterans' experience with VA care. | Health Serv Res | 2019 |
| 31173123 | Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users. | JAMA Netw Open | 2019 |
| 30377384 | Stakeholders' views on the value of outcomes from clinical genetic and genomic interventions. | Genet Med | 2019 |
| 29339012 | Patient-Rated Access to Needed Care: Patient-Centered Medical Home Principles Intertwined. | Womens Health Issues | 2018 |
| 30017475 | Mental Health Screening Results Associated with Women Veterans' Ratings of Provider Communication, Trust, and Care Quality. | Womens Health Issues | 2018 |
| 25847643 | Early diffusion of gene expression profiling in breast cancer patients associated with areas of high income inequality. | Health Aff (Millwood) | 2015 |
| 24672053 | Reciprocal knock-in mice to investigate the functional redundancy of lamin B1 and lamin B2. | Mol Biol Cell | 2014 |
| 23650370 | Farnesylation of lamin B1 is important for retention of nuclear chromatin during neuronal migration. | Proc Natl Acad Sci U S A | 2013 |
| 22416132 | Understanding the roles of nuclear A- and B-type lamins in brain development. | J Biol Chem | 2012 |
| 22308344 | Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA. | Proc Natl Acad Sci U S A | 2012 |
| 21647293 | Investigating the purpose of prelamin A processing. | Nucleus | 2011 |
| 22127257 | Are B-type lamins essential in all mammalian cells? | Nucleus | 2011 |
| 21976703 | Deficiencies in lamin B1 and lamin B2 cause neurodevelopmental defects and distinct nuclear shape abnormalities in neurons. | Mol Biol Cell | 2011 |
| 20145110 | Abnormal development of the cerebral cortex and cerebellum in the setting of lamin B2 deficiency. | Proc Natl Acad Sci U S A | 2010 |
| 21278813 | LINCing lamin B2 to neuronal migration: growing evidence for cell-specific roles of B-type lamins. | Nucleus | 2010 |
| 20439468 | Direct synthesis of lamin A, bypassing prelamin a processing, causes misshapen nuclei in fibroblasts but no detectable pathology in mice. | J Biol Chem | 2010 |
| 19453251 | The posttranslational processing of prelamin A and disease. | Annu Rev Genomics Hum Genet | 2009 |
| 19376814 | Activating the synthesis of progerin, the mutant prelamin A in Hutchinson-Gilford progeria syndrome, with antisense oligonucleotides. | Hum Mol Genet | 2009 |
| 18230615 | A potent HIV protease inhibitor, darunavir, does not inhibit ZMPSTE24 or lead to an accumulation of farnesyl-prelamin A in cells. | J Biol Chem | 2008 |
| 18789316 | Development of the vertebral morphogenetic field in the mouse: interactions between Crossveinless-2 and Twisted Gastrulation. | Dev Biol | 2008 |
| 18639527 | HIV-protease inhibitors block the enzymatic activity of purified Ste24p. | Biochem Biophys Res Commun | 2008 |
| 18694564 | Crossveinless-2 Is a BMP feedback inhibitor that binds Chordin/BMP to regulate Xenopus embryonic patterning. | Dev Cell | 2008 |
| 17652517 | HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells. | Proc Natl Acad Sci U S A | 2007 |
| 16484451 | A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria. | Science | 2006 |
| 16862216 | A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation. | J Clin Invest | 2006 |
| 15142986 | Selective deletion of the Hnf1beta (MODY5) gene in beta-cells leads to altered gene expression and defective insulin release. | Endocrinology | 2004 |
| 11934849 | Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1beta. | Development | 2002 |